Original news and analysis on international IP policy
The International Trademark Association (INTA) will implement a new strategic plan for 2018 to 2021 starting with the new year. The plan focuses on promoting the value of trademarks and brands, reinforcing consumer trust, and embracing innovation and change.
After two decades of intellectual property regimes in trade agreements, one could have some second thoughts, according to a number of panellists at the Trade and Sustainable Development Symposium, organised by the International Centre for Trade and Sustainable Development (ICTSD) and held alongside the 11th World Trade Organization Ministerial in Buenos Aires, Argentina this week.
Since the U.S. Court of Appeals for the Federal Circuit issued its opinion in Arendi S.A.R.L. v. Apple Inc. last August,[1] many patent commentators have asserted that the decision marked a significant change in the analysis of obviousness under 35 U.S.C. § 103, especially as a weakening of single-reference obviousness grounds. Notwithstanding this decision, petitioners and the Patent Trial and Appeal Board have continued to rely on single-reference obviousness to assert and find that claims are obvious, write Amy Simpson and Kyle Canavera.
A report released today on global funding of research and development for neglected diseases found that global funding has increased but warns that overreliance on funding from the United States, which the report says is "unparalleled," and leads to a heavy concentration of global funding on HIV/AIDS, malaria and tuberculosis. This overreliance could also lead to change in total global funding, the report found.
The European Parliament today adopted a report that lays out a European digital trade strategy. Adopted by a margin of 510 to 95 in Strasbourg, the report obliges the Commission to make digital trade an essential part in the European trade policy.
The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications.
The first biosimilar of the blockbuster breast cancer drug trastuzumab is being prepared for launch in United States, following a decision by the Food and Drug Administration (FDA) to approve it earlier this month. The product, Ogivri, has been created by a joint venture between US Mylan and Indian company Biocon.
The European Patent Office (EPO) today announced a study that showed "European patent applications related to smart connected objects are rising rapidly, achieving a growth rate of 54% in the last three years."
NEW YORK -- A panel at the recent IP Dealmakers Forum including a US Federal Trade Commission official, a former US judge on a key patent case, and a telecommunications industry licensing expert walked through issues and prospects for the coming of the 5G next generation wireless technology. Views differed on points but panellists agreed that changes are needed to the system for standard-essential patents, including a bigger role for standard-setting organisations. Below is an in-depth account of the discussion. The discussion also included the latest state-of-play at the FTC, which currently has its lowest number of commissioners ever.
A new European Union ancillary copyright provision for news publishers will help them against news aggregators and platform providers, promised proponents and two panellists favouring the addition of the EU Copyright Reform at a workshop of the Justice Committee (JURI) of the European Parliament in Brussels today (7 December). But it’s a promise that cannot be kept according to a study commissioned by the Parliament and also presented during a feisty discussion at the workshop.
Should the European Parliament consider regulation on 3D printing with regard to intellectual property protection and civil liability? Members of the Justice Committee (JURI) today at their session in Brussels were divided with representatives from the Green Party group as well as the conservatives and liberals cautioning against erecting barriers to the technology.
In an extraordinary 6 December session, the UN International Labour Organization Administrative Tribunal (ILOAT) handed down five decisions involving the European Patent Office (EPO), one of which reinstated a suspended Board of Appeals judge. The cases are just “the tip of the iceberg,” said the Staff Union of the EPO (SUEPO).